Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity.
about
Anticholinergic drugs versus placebo for overactive bladder syndrome in adultsThe analysis of incontinence episodes and other count data in patients with overactive bladder by Poisson and negative binomial regression.Tolterodine for the treatment of overactive bladder: a review.The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.Solifenacin for overactive bladder: a systematic review and meta-analysis.Patient-perceived effectiveness and impact on quality of life of solifenacin in combination with an α-blocker in men with overactive bladder in Sweden: a non-interventional study.A clinical perspective on the analysis and presentation of the number of incontinence episodes following treatment for OAB.Clinical guidelines for overactive bladder.Development of a core set of outcome measures for OAB treatment.Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder.Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome.Antimuscarinic drugs for the treatment of female urinary incontinence.
P2860
Q24243870-594BE61E-2BF1-4026-AEEA-897707A61671Q30880978-1ABCB38F-2C20-4FF7-87F7-8267A74F1EF0Q36150735-3C56648F-F2B0-4857-A3AA-4197A2F0FFABQ36428471-E559128B-DAE2-41AE-A5E2-12BF329241B8Q37187453-4ECFD8C3-8E14-4743-A89F-93D8DD7BE0DBQ37981898-5E8DC49B-D163-4B74-872F-774EDD0898E9Q38634816-DE3C9D6D-8CD7-4955-9E62-20A808B2EAE7Q40988066-2EED6D88-6976-46B2-8DC7-8E6B81D0F7ECQ46116817-0B205C82-5D2E-43AD-BD37-78A37020722EQ47095229-B8BF2D20-E0C0-4227-A58B-26D74A61199AQ50907877-807E165F-CCBC-45B9-A7A5-36D2FC77EC56Q51474348-C51FBEC2-7B66-4384-BC54-FA00A154086AQ51817526-E077FD3C-9866-4B74-87E3-8BC5F9D6189D
P2860
Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Efficacy of antimuscarinic the ...... rees of incontinence severity.
@en
Efficacy of antimuscarinic the ...... rees of incontinence severity.
@nl
type
label
Efficacy of antimuscarinic the ...... rees of incontinence severity.
@en
Efficacy of antimuscarinic the ...... rees of incontinence severity.
@nl
prefLabel
Efficacy of antimuscarinic the ...... rees of incontinence severity.
@en
Efficacy of antimuscarinic the ...... rees of incontinence severity.
@nl
P2093
P1476
Efficacy of antimuscarinic the ...... rees of incontinence severity.
@en
P2093
Eboo Versi
Steve Kaplan
Steve Swift
P304
P356
10.1097/01.JU.0000103540.71683.E5
P407
P433
P577
2004-02-01T00:00:00Z